NASA and Arizona State University’s Biodesign Institute have entered a Space Act Agreement for vaccine research on the International Space Station (ISS). Under the nonreimbursable agreement, a team headed by Cheryl Nickerson, an associate professor of life sciences at the university, will continue work started on the space shuttle that takes advantage of the effects of microgravity on infectious microorganisms to produce vaccines against disease. The Arizona State group joins ...
THIS CONTENT REQUIRES SUBSCRIPTION ACCESS
You must have an Aviation Week Intelligence Network (AWIN) account or subscribe to this Market Briefing to access "Arizona State Will Study Vaccines On ISS".
Current Aviation Week Intelligence Network (AWIN) enterprise and individual members: please go to http://awin.aviationweek.com for access.
Not currently a subscriber? Click on the "Learn More" button below to view subscription offers.